Saturn V Capital Management Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$552.2M
Q ending 2026-03-31
Prior quarter
$544.9M
Q ending 2025-12-31
Change
+1.3% QoQ · +178.7% YoY
Positions
21
reported holdings
Largest positions
All 21 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Alumis Inc | ALMS | Shares | $70.5M | 3.2M |
| Amylyx Pharmaceuticals Inc | AMLX | Shares | $60.5M | 4.3M |
| Abivax Sa | ABVX | Shares | $60.4M | 543K |
| Vaxcyte Inc | PCVX | Shares | $47.9M | 825K |
| Pharvaris N V | Shares | $33.9M | 1.2M | |
| Immix Biopharma Inc | IMMX | Shares | $33.6M | 3.7M |
| Celcuity Inc | CELC | Shares | $32.2M | 282K |
| Jazz Pharmaceuticals Plc | Shares | $30.8M | 163K | |
| Disc Medicine Inc | IRON | Shares | $28.8M | 450K |
| X4 Pharmaceuticals Inc | XFOR | Shares | $26.7M | 6.5M |
| Cogent Biosciences Inc | COGT | Shares | $24.1M | 627K |
| Monopar Therapeutics Inc | MNPR | Shares | $18.9M | 346K |
| Dyne Therapeutics Inc | DYN | Shares | $17.5M | 967K |
| Invivyd Inc | IVVD | Shares | $14.2M | 10.9M |
| Candel Therapeutics Inc | CADL | Shares | $14.2M | 2.9M |
| Oculis Holding Ag | Shares | $13.7M | 517K | |
| Ovid Therapeutics Inc | OVID | Shares | $9.2M | 4.2M |
| Inhibikase Therapeutics Inc | IKT | Shares | $6.5M | 3.9M |
| Zura Bio Ltd | Shares | $4.4M | 740K | |
| Alto Neuroscience Inc | ANRO | Shares | $2.0M | 89K |
| Satellos Bioscience Inc | MSLE | Shares | $2.0M | 350K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.